Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc.（CGEM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CGEM · 截至 2026年6月8日
活动摘要
买入笔数
8
P-Purchase only
卖出笔数
25
近12个月
买卖比
0.32
Buy/Sell (by trades)
整体情绪
Cullinan Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CGEM 季度内部人买卖趋势
CGEM 内幕交易卖出 · CGEM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CGEM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CGEM 高管卖出股份 · CGEM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 5, 2026 | Michaelson Jennifer Chief Scientific Officer | Option | 4,000 | $17K | Form 4 |
| May 5, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 7,800 | $114K | Form 4 |
| May 5, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 200 | $3K | Form 4 |
| Mar 5, 2026 | Michaelson Jennifer Chief Scientific Officer | Option | 4,000 | $17K | Form 4 |
| Mar 5, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 8,000 | $125K | Form 4 |
| Feb 25, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 1,780 | $25K | Form 4 |
| Feb 23, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 1,752 | $25K | Form 4 |
| Feb 24, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 3,601 | $52K | Form 4 |
| Feb 24, 2026 | AHMED NADIM President and CEO · Director | Sale | 13,515 | $196K | Form 4 |
| Feb 24, 2026 | Jones Jeffrey Alan Chief Medical Officer | Sale | 4,582 | $66K | Form 4 |
| Feb 24, 2026 | SUMER JACQUELYN L Chief Legal Officer | Sale | 3,601 | $52K | Form 4 |
| Feb 20, 2026 | Jones Jeffrey Alan Chief Medical Officer | Sale | 4,982 | $68K | Form 4 |
| Feb 20, 2026 | Michaelson Jennifer Chief Scientific Officer | Option | 8,000 | $34K | Form 4 |
| Feb 20, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 8,000 | $114K | Form 4 |
| Feb 20, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 3,742 | $51K | Form 4 |
| Feb 20, 2026 | SUMER JACQUELYN L Chief Legal Officer | Sale | 3,742 | $51K | Form 4 |
| Feb 20, 2026 | AHMED NADIM President and CEO · Director | Sale | 16,381 | $223K | Form 4 |
| Feb 20, 2026 | Fenton Mary Kay CFO | Sale | 4,398 | $60K | Form 4 |
| Feb 18, 2026 | Fenton Mary Kay CFO | Award | 68,750 | — | Form 4 |
| Feb 18, 2026 | Michaelson Jennifer Chief Scientific Officer | Award | 57,500 | — | Form 4 |
| Feb 12, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 416 | $5K | Form 4 |
| Jan 22, 2026 | Michaelson Jennifer Chief Scientific Officer | Sale | 4,000 | $49K | Form 4 |
| Dec 31, 2025 | Fenton Mary Kay CFO | Award | 27 | $175 | Form 4 |
| Dec 23, 2025 | AHMED NADIM President and CEO · Director | Sale | 9,922 | $99K | Form 4 |
| Dec 19, 2025 | Michaelson Jennifer Chief Scientific Officer | Sale | 1,345 | $13K | Form 4 |
Michaelson Jennifer
Chief Scientific Officer
日期
Feb 20
股数
8,000
均价
$4.30
总金额
$34K
Michaelson Jennifer
Chief Scientific Officer
日期
Feb 20
股数
8,000
均价
$14.30
总金额
$114K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CGEM 内幕交易
CGEM 内幕交易
Cullinan Therapeutics, Inc.（CGEM）内幕交易数据来源于公司内部人（包括Michaelson Jennifer (Chief Scientific Officer), Lynx1 Capital Management LP (10 percent owner), AHMED NADIM (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CGEM内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cullinan Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CGEM 内幕交易 · 5个问题Cullinan Therapeutics, Inc.（CGEM）的内部人包括高管和董事，如Michaelson Jennifer (Chief Scientific Officer), Lynx1 Capital Management LP (10 percent owner), AHMED NADIM (President and CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026